Abstract
We examined a possible role for the adhesion molecules LFA-1 and ICAM-1 in localizing central nervous system non-Hodgkin's lymphomas (CNS-NHLs) to the brain. Fresh frozen sections from 12 monoclonal CNS NHLs (11 primary, one secondary) were stained with monoclonal antibodies to LFA-1 α chain (CD11a), β chain (CD18) and, ICAM-1 (CD54). Additional staining made use of rat monoclonal antibodies to the human and mouse high endothelial venule antigens HECA 452 and MECA 79 and mouse ICAM-1. The expression of these same molecules was also studied in mice with severe combined immunodeficiency (SCID) mice, bearing intracranial human lymphoblastoid cells.
Eleven of the CNS-NHL tumors expressed LFA-1α (one strongly, one intermediate, nine weakly). Nine of the tumors weakly expressed LFA-1β.. Nine of twelve tumors weakly expressed ICAM-1. In six of seven tumors definite blood vessels stained for ICAM-l. Non-tumor brain from two patients and non-tumor cerebral blood vessels showed no staining with CD11a, CD18 or CD54 antibodies. Strong expression of LFA-α and LFA-β as well as ICAM-1 was noted in human lymphoblastoid cells (LCLs)/SCID mouse CNS lymphomas. Tumor blood vessels in these mice stained for mouse ICAM-1. Normal SCID mouse brains showed no staining with CDIIα, CD18, CD54 or mouse ICAM-1 antibodies. Human, human/mouse CNS lymphomas, normal human, and mouse brains showed no staining with either HECA 452 or MECA 79.
Our data suggests that CNS lymphomas express LFA-1α, LFA-1β and to a lesser degree ICAM-1 antigen, while tumor blood vessel endothelium expresses ICAM-1. LFA-1α-LFA-1β/ICAM-1 interaction may play a role in large cell lymphoma homing and persistence in the brain.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bailey P: Intracranial sarcomatous tumors of leptomeningeal origin. Arch Surg 18: 1359–1402, 1929
Schaumberg HH, Plank CR, Adams RD: The reticulum cell sarcoma microglioma group of brain tumors: a consideration of their clinical features and therapy. Brain 95: 199–212, 1972
Bashir R, Harris N, Bain K, Nadler L, Hochberg F: Immunophenotypic profile of CNS lymphoma: A review of eighteen cases. J Neuroonc 7: 249–254, 1989
Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835–853, 1988
Schneck SA, Penn I: De-novo brain tumours in renal-transplant recipients. Lancet 1: 983–986, 1971
Rosenblum ML, Levy RM, Bredesen DE et al.: Primary central nervous system lymphomas in patients with AIDS. Ann Neurol (Suppl) 23(5): 13–18, 1986
So YT, Beckstead J, Davis RL: Primary central nervous system lymphoma in acquired immunodeficiency syndrome. A clinical and pathological study. Ann Neurol 20: 566–577, 1986
Zeigler JL, Beckstead JA, Volverding PA: Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. Cancer 56: 2831–2842, 1985
Eby NL, Grufferman S, Flannelli CM, Schold SC, Vogel S, Burger PC: Increasing incidence of primary CNS lymphoma in the US. Cancer 62: 2461–2465, 1988
Medewar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29: 58–69, 1948
Gowans JL, Knight EJ: The route of recirculation of lymphocytes. Proc R Soc London, Ser B 159: 257–266, 1964
Talkanen ST, Riechert RA, Gallatin WM, Bargatze RF, Weissman E, Butcher EC: Homing receptors and the control of lymphocyte migration. Immunol Rev 91: 39–60, 1986
Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maker D, Salvaris E, Welch K, Fecondo J, Boyd AW: The role of the LFA-1/ICAM-I interaction in human leukocyte homing and adhesion. Immunol Rev 108: 135–161, 1989
Patarroyo M, Makogoba MW: Leukocyte to cells. Molecular basis, physiological relevance and abnormalities. Scand J Immunol 30: 129–164, 1989
Patarroyo M, Prieto J, Rincon J, Timonen T, Lundberg C, Lindbom L, Asjo B, Gahmberg CG: Leukocyte-cell adhesion: A molecular process fundamental in leukocyte physiology. Immuno Rev 114: 67–108, 1990
Duijestyn AM, Horst E, Pols ST, Rouse BN: High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Amer J Pathol 130: 147–155, 1988
Jalkanen ST, Bargatze RF, Herron LR, Butcher EC: A lymphocyte surface glycoprotein involved in endothelial cell recognition and lymphocyte in man. Eur J Immunol 16: 1195–1202, 1986
Jalkanen S, Reichert RA, G1latin WM, Bargatze RF, Weissman IL, Butcher EC: Homing receptors and the control of lymphocyte migration. Immuno Rev 91: 39–60, 1986
Streeter PR, Rouse BT, Butcher EC: Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107: 1853–1862, 1988
Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 51: 813–819, 1987
Frohman EM, Van DenNoort S, Gupta S: Astrocytes and intracerebral immune responses. J Clin Immunol 9(1): 1–9, 1989
Roosien FF, deRijk D, Bikker A, Roos E: Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1 deficient mutants. J Cell Biol 108: 1979–1985, 1989
Bosma GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature 201: 527–530, 1983
Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (Lond) 335: 256–259, 1988
Bashir RM, Okano M, Kleveland K, Purtilo D: Tumorigenicity of LCL's in SCID/SCID CB17 mouse brain following intracerebral injections. Primary CNS lymphoma model. Internat J Cancer (Submitted)
Nilsson K, Giovanella BC, Stehlin JS: Tumorigenicity of human hematopoietic cell-lines in athymic nude mice. Int J Cancer 19: 337–342, 1977
Giovanella B, Nilsson K, Jack L et al.: Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid celllines heterotransplanted into nude mice under immunologically privileged conditions. Int J Cancer 24: 103–113, 1979
Thorley-Lawson DA: Basic virological aspects of Epstein-Barr virus infection. Seminars in Hematol 25(3): 247–260, 1988
Klein G: Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58: 5–8, 1989
Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen TL: Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoprotiferative disease. N Engl J Med 321(16):1080–1085, 1989
Takei F: Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 85: 1403–1407, 1985
National Cancer Institute: Summary and description of a working formulation for clinical usage: the non-Hodgkin's lymphoma pathologic classification project. Cancer 49: 2112–2135, 1982
Gregory CD, Murray RT, Edwards CF, Rickinson AB: Downregulation of all adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus — positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 167: 1811–1824, 1988
Bashir RM, Dembimski A, Masih A: CNS lymphoproliferation in a patient with AIDS. Manuscript in preparation
Rossen RD, Smith CW, Laughter AM, Noonan C, Anderson DC: HIV-1 stimulated expression of CD11/CD18 and LCAM-1 in monocytes and T cells: A possible mechanism of extravascular dissemination of HIV-infected cells (Abstr). Clin Res 37: 608A, 1989
Bashir RM, Harris NL, Hochberg FH, Singer R: Detection of Epstein-Barr virus in primary CNS lymphoma in immunocompromised patients. Neurol (6): 813–817, 1989
Bashir RM, Harris NL, Hochberg FH, Purtilo D: Variable expression of Epstein-Barr virus in CNS lymphoma in immunocompromised patients as detected by in situ hybridization. Moder Pathol (In press)
Pelicci P-G, Knowles II DM, Arlin ZA et al.: Multiple monoclonal B cell expression and C-myc oncogene rearrangements in acquired immunodeficiency syndrome-related lymphoproliferative disorders; implications for lymphogenesis. J Exp Med 164: 2049–2076, 1986
Ernberg I: Epstein-Barr virus and acquired immunodeficiency syndrome. Adv Viral Oncol 8: 20–217, 1989
Kupner MC, Hamou MF, Sawamura Y, Tribolet N de: Cytokine regulation of intracellular adhesion molecule 1 (ICAMOt) expression on human glioblastoma cells. J Neuroonc 7 (Suppl): 57, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bashir, R., Coakham, H. & Hochberg, F. Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neuro-Oncol 12, 103–110 (1992). https://doi.org/10.1007/BF00172658
Issue Date:
DOI: https://doi.org/10.1007/BF00172658